Seoul National University Bundang Hospital (SNUBH)
No hidden fees – just official clinic prices. Pay at the clinic for Optic nerve atrophy treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Optic nerve atrophy treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Optic nerve atrophy treatment journey.
Dr. Nam Sanghyu is a board-certified ophthalmologist at Asan Medical Center. He is a Clinical Specialist and Clinical Professor. His practice focuses on cataract and presbyopia. He also treats cornea and ocular surface disease, including dry eye, external eye disease, and tear duct problems. He manages retina and glaucoma disorders, including diabetic retinopathy and macular degeneration.
Accreditations: Full Member of KOS, KDES, KCDS, KSCRS, and the Korean Contact Lens Study Society. Regular Member of ASCRS, ESCRS, and APACRS.
Publications: Scientific Reports (2022) on big data linking air pollution and conjunctivitis. Ophthalmologica (2021) on OCTA after repair of macula-off rhegmatogenous retinal detachment. Journal of the Korean Ophthalmological Society (2021) on blue light and polyphenolic protection.
Dr. Byung-hee Lee is a neurosurgeon at RE:YOUTH Clinic in South Korea. He is a founding member of the Korean Society of Interventional Neurology. He also helped found the Korean Stroke Society. Dr. Lee treats complex conditions like Parkinson's, Alzheimer's, and cerebral aneurysms.
Optic nerve atrophy cannot be fully cured in South Korea. Modern medicine cannot yet regenerate dead nerve fibres to restore lost vision. South Korean specialists focus on stopping progression. They treat underlying causes and use diagnostics to preserve any remaining sight.
Bookimed Expert Insight: South Korea is a global medical hub ranked 3rd in our database. While a cure remains elusive, clinics like RE:YOUTH specialise in regenerative medicine. They offer arterial stem cell therapy for chronic conditions. This high-level research focus means patients access the latest neuroprotective strategies before they become global standards.
Patient Consensus: Patients note that preventing further loss is a more realistic goal than regaining sight. They emphasise that managing the root cause is vital for long-term stability. In the Republic of Korea, this often includes managing intracranial pressure.
South Korea offers regenerative medicine and neuro-ophthalmological research for optic nerve atrophy. Specialists use stem cell therapy to repair damaged neural tissues and retinal ganglion cells. Institutions like Severance Hospital and Samsung Medical Center often lead these clinical efforts. They use advanced drug delivery and electrical stimulation.
Bookimed Expert Insight: South Korea ranks globally for medical innovation. However, patients must distinguish between research and available care. RE:YOUTH Clinic is unique as Korea's only facility performing arterial stem cell therapy. This method delivers cells directly via the artery. This may offer more targeted delivery than standard injections for complex neurological conditions.
Patient Consensus: Patients note that regenerative eye treatments in South Korea are often part of clinical trials. They emphasise researching clinic credentials carefully. They also focus on verified neuro-ophthalmology specialists rather than general vision correction clinics.
South Korean clinics administer autologous stem cells for optic nerve atrophy. They use targeted ocular injections and systemic infusions. Specialists use retrobulbar, subtenon, and intravitreal techniques to deliver cells near the nerve. These procedures typically occur in JCI-accredited facilities using cell processing technology.
Bookimed Expert Insight: While many centres focus on local injections, South Korea stands out for arterial delivery methods. For example, RE:YOUTH clinic offers direct arterial infusion, a technique designed to bypass systemic filters. This approach targets complex chronic conditions more aggressively than standard intravenous drips.
Patient Consensus: Patients note that local injections are common. However, results often vary between corneal repair and true nerve regeneration. Many emphasise the importance of confirming the specific cell type and clinical trial status before starting treatment in South Korea.
Diagnostic procedures for optic nerve atrophy in South Korea include advanced imaging and electrophysiological tests. Specialists use Optical Coherence Tomography (OCT) to measure nerve fibre thickness. Visual Evoked Potentials (VEP) and perimetry assess nerve function. JCI-accredited Seoul hospitals often require brain MRIs to identify underlying causes.
Bookimed Expert Insight: South Korea ranks 3rd globally for medical requests on our platform. Major centres like Asan Medical Center handle 65,000+ operations annually. Their diagnostic depth is notable. While many clinics offer basic eye checks, top Seoul hospitals integrate neurology and ophthalmology. This ensures atrophy caused by brain pressure or tumours is not missed.
Patient Consensus: South Korean clinics provide detailed pre-treatment exams covering corneal thickness and eye dryness. Patients emphasise bringing Australian eye history and scans. They note the focus remains on stabilising vision and managing underlying causes like intracranial pressure.
South Korean doctors treat optic nerve atrophy by stabilising eye pressure to prevent further sight loss. Specialist centres in Seoul use diagnostics like SD-OCT and AS-OCT. While nerve damage is permanent, JCI-accredited facilities offer minimally invasive glaucoma surgery and laser therapy to protect remaining vision.
Bookimed Expert Insight: South Korea is a leader in digital health integration. Seoul National University Bundang Hospital was the nation's first fully digital hospital. This interconnectivity allows specialists to compare year-over-year OCT scans with extreme precision. For Australian patients, this data-driven approach helps specialists set highly accurate target eye pressures to stop nerve decay.
Patient Consensus: Patients note that Korean specialists focus heavily on stabilising eye pressure through drops or surgery. They advise bringing previous visual field tests from Australia. These help doctors judge how much vision is salvageable.
South Korean centres lead in treating optic nerve atrophy. Seoul National University Bundang Hospital (SNUBH) is a prominent example. These centres specialise in neuro-ophthalmology and regenerative medicine research. Patients access high-density diagnostic imaging within JCI-accredited environments. This includes Optical Coherence Tomography (OCT). Treatment focus remains on neuroprotection and precise visual pathway evaluation.
Bookimed Expert Insight: South Korea's eye care is unique because major university hospitals host dedicated eye clinics. SNUBH is ranked among the world's best smart hospitals by Newsweek. This digital integration means diagnostic scans are analysed with extreme precision. Patients benefit from quicker specialist reviews compared to traditional clinics. This speed is vital for managing progressive nerve conditions effectively.
Patient Consensus: Patients often mention the efficiency of Seoul's medical systems and the kindness of hospital staff. They appreciate the detailed explanations provided after complex ophthalmological investigations and scans.